Sfoglia per Autore
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma
2026-01-01 Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma
2026-01-01 Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform
2025-01-01 Mosquera Orgueira, Adrian; Gonzalez Perez, Marta Sonia; D'Agostino, Mattia; Cairns, David A.; Larocca, Alessandra; Palacios, Juan José Lahuerta; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Pérez Míguez, Carlos; Rojas Martínez, Javier Alberto; Mai, Elias K.; Crucitti, Davide; Salwender, Hans; Dall'Olio, Daniele; Castellani, Gastone; Piñeiro Fiel, Manuel; Bringhen, Sara; Zweegman, Sonja; Cavo, Michele; Iqbal, Sofía; Hernandez Rivas, Jesus Maria; Bruno, Benedetto; Cook, Gordon; Kaiser, Martin F.; Goldschmidt, Hartmut; Van De Donk, Niels W. C. J.; Jackson, Graham; San‐Miguel, Jesús F.; Boccadoro, Mario; Mateos, Maria‐Victoria; Sonneveld, Pieter
Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial
2025-01-01 Bringhen, Sara; Cani, Lorenzo; Giuliani, Nicola; Mangiacavalli, Silvia; Benevolo, Giulia; Antonioli, Elisabetta; Zambello, Renato; Ria, Roberto; Vincelli, Iolanda Donatella; Ronconi, Sonia; More, Sonia; Falcone, Antonietta Pia; Allegra, Alessandro; D'Agostino, Mattia; Evangelista, Andrea; Capra, Andrea; Sciorsci, Elisa; Curci, Paola; Tosi, Patrizia; Liberati, Anna Marina; Cafro, Anna Maria; Belotti, Angelo; Patriarca, Francesca; Mannina, Donato; Mancuso, Katia; Cattel, Francesco; Ciccone, Giovannino; Bruno, Benedetto; Boccadoro, Mario; Larocca, Alessandra
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomib
2025-01-01 Bertuglia, Giuseppe; Verardo, Mattia; Scaldaferri, Matilde; Mangiapia, Mauro; Bruno, Benedetto; Larocca, Alessandra
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network
2025-01-01 Gerotziafas, Grigoris; Fotiou, Despina; Nijhof, Inger; Ay, Cihan; Lecumberri, Ramon; Larocca, Alessandra; Cook, Gordon; Engelhardt, Monika; Zweegman, Sonja; Delforge, Michel; Maraveyas, Anthony; Lefkou, Eleftheria; Marchetti, Marina; Van de Donk, Niels W. C. J.; Gay, Francesca; Ludwig, Heinz; Einsele, Hermann; San Miguel, Jesus F.; Dimopoulos, Meletios A.; Boccadoro, Mario; Sonneveld, Pieter; Falanga, Anna; Terpos, Evangelos
Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial
2025-01-01 Richardson, Paul; Beksaç, Meral; Oriol, Albert; Lindsay, Jindriska; Schjesvold, Fredrik; Galli, Monica; Yağcı, Münci; Larocca, Alessandra; Weisel, Katja; Yu, Xin; Donahue, Cynthia; Acosta, Jorge; Peluso, Teresa; Dimopoulos, Meletios
Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
2025-01-01 Kaiser, Martin F; Sonneveld, Pieter; Cairns, David A; Raab, Marc S; San-Miguel Izquierdo, Jesús; Zhang, Rick; Acosta, Jorge; Larocca, Alessandra; Popat, Rakesh; Li, Cong; Baertsch, Marc-A; Brown, Sarah R; Lahuerta Palacios, JuanJose; Gandhi, Anita K; Macé, Sandrine; Musto, Pellegrino; Yong, Kwee; Mai, Elias K; Dubin, Franck; Blade, Joan; Capra, Andrea; Cook, Gordon; Bertsch, Uta; Mateos, María-Victoria; Boccadoro, Mario; Jackson, Graham H; Gutiérrez, Norma C; Gay, Francesca; Weinhold, Niels
Carfilzomib–lenalidomide–dexamethasone versus lenalidomide–dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial
2025-01-01 Bringhen, Sara; Cani, Lorenzo; Antonioli, Elisabetta; Derudas, Daniele; Fazio, Francesca; Larocca, Alessandra; Ronconi, Sonia; Cellini, Claudia; Falcone, Antonietta Pia; Accardi, Fabrizio; Liberati, Anna Marina; Galieni, Piero; Belotti, Angelo; Cafro, Anna Maria; Ria, Roberto; Benevolo, Giulia; Vincelli, Iolanda Donatella; Mannina, Donato; Lotti, Flavia; Bruno, Benedetto; Marasco, Vincenzo; Mazza, Rita; Tosi, Patrizia; Rivolti, Elena; Boccadoro, Mario; D'Agostino, Mattia
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024-01-01 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor
2024-01-01 Bertuglia, Giuseppe; Garibaldi, Bruno; Casson, Andrea; Sarina, Barbara; Gay, Francesca; Mercadante, Silvio; Mariotti, Jacopo; D'agostino, Mattia; Taurino, Daniela; Oliva, Stefania; Larocca, Alessandra; Mannina, Daniele; De Philippis, Chiara; Benevolo, Giulia; Francisci, Tiziana; Lorenzi, Marco; Bruno, Benedetto; Santoro, Armando; Bringhen, Sara; Mina, Roberto; Bramanti, Stefania
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
2024-01-01 Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
2024-01-01 Schjesvold, Fredrik H.; Ludwig, Heinz; Mateos, Maria‐Victoria; Larocca, Alessandra; Abdulhaq, Haifaa; Norin, Stefan; Thuresson, Marcus; Bakker, Nicolaas A.; Richardson, Paul G.; Sonneveld, Pieter
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
2024-01-01 Oriol, Albert; Dimopoulos, Meletios; Schjesvold, Fredrik; Beksac, Meral; Facon, Thierry; Dhanasiri, Sujith; Guo, Shien; Mu, Yutian; Hong, Kevin; Gentili, Christian; Galli, Monica; Yagci, Munci; Larocca, Alessandra; Richardson, Paul; Weisel, Katja
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
2023-01-01 Mian, Hira; McCurdy, Arleigh; Giri, Smith; Grant, Shakira; Rochwerg, Bram; Winks, Erica; Rosko, Ashley E; Engelhardt, Monika; Pawlyn, Charlotte; Cook, Gordon; Jackson, Graham; Bringhen, Sara; Facon, Thierry; Larocca, Alessandra; Zweegman, Sonja; Wildes, Tanya M
New Strategies for the Treatment of Older Myeloma Patients
2023-01-01 Larocca, Alessandra; Cani, Lorenzo; Bertuglia, Giuseppe; Bruno, Benedetto; Bringhen, Sara
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023-01-01 Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
2022-01-01 Larocca A.; Leleu X.; Touzeau C.; Blade J.; Paner A.; Mateos M.-V.; Cavo M.; Maisel C.; Alegre A.; Oriol A.; Raptis A.; Rodriguez-Otero P.; Mazumder A.; Laubach J.; Nadeem O.; Sandberg A.; Orre M.; Torrang A.; Bakker N.A.; Richardson P.G.
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study
2022-01-01 Efficace, Fabio; Gaidano, Gianluca; Petrucci, Maria Teresa; Niscola, Pasquale; Cottone, Francesco; Codeluppi, Katia; Antonioli, Elisabetta; Tafuri, Agostino; Larocca, Alessandra; Potenza, Leonardo; Fozza, Claudio; Pastore, Domenico; Rigolin, Gian Matteo; Offidani, Massimo; Romano, Alessandra; Kyriakou, Charalampia; Cascavilla, Nicola; Gozzetti, Alessandro; Derudas, Daniele; Vignetti, Marco; Cavo, Michele
Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel
2022-01-01 De Stefano, Valerio; Larocca, Alessandra; Carpenedo, Monica; Cavo, Michele; Di Raimondo, Francesco; Falanga, Anna; Offidani, Massimo; Petrucci, Maria Teresa; Ruggeri, Marco; Santi, Roberto Mario; Barosi, Giovanni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma | 2026 | Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto | |
| MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma | 2026 | Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto | |
| Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform | 2025 | Mosquera Orgueira, Adrian; Gonzalez Perez, Marta Sonia; D'Agostino, Mattia; Cairns, David A.; Larocca, Alessandra; Palacios, Juan José Lahuerta; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Pérez Míguez, Carlos; Rojas Martínez, Javier Alberto; Mai, Elias K.; Crucitti, Davide; Salwender, Hans; Dall'Olio, Daniele; Castellani, Gastone; Piñeiro Fiel, Manuel; Bringhen, Sara; Zweegman, Sonja; Cavo, Michele; Iqbal, Sofía; Hernandez Rivas, Jesus Maria; Bruno, Benedetto; Cook, Gordon; Kaiser, Martin F.; Goldschmidt, Hartmut; Van De Donk, Niels W. C. J.; Jackson, Graham; San‐Miguel, Jesús F.; Boccadoro, Mario; Mateos, Maria‐Victoria; Sonneveld, Pieter | |
| Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial | 2025 | Bringhen, Sara; Cani, Lorenzo; Giuliani, Nicola; Mangiacavalli, Silvia; Benevolo, Giulia; Antonioli, Elisabetta; Zambello, Renato; Ria, Roberto; Vincelli, Iolanda Donatella; Ronconi, Sonia; More, Sonia; Falcone, Antonietta Pia; Allegra, Alessandro; D'Agostino, Mattia; Evangelista, Andrea; Capra, Andrea; Sciorsci, Elisa; Curci, Paola; Tosi, Patrizia; Liberati, Anna Marina; Cafro, Anna Maria; Belotti, Angelo; Patriarca, Francesca; Mannina, Donato; Mancuso, Katia; Cattel, Francesco; Ciccone, Giovannino; Bruno, Benedetto; Boccadoro, Mario; Larocca, Alessandra | |
| Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomib | 2025 | Bertuglia, Giuseppe; Verardo, Mattia; Scaldaferri, Matilde; Mangiapia, Mauro; Bruno, Benedetto; Larocca, Alessandra | |
| Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network | 2025 | Gerotziafas, Grigoris; Fotiou, Despina; Nijhof, Inger; Ay, Cihan; Lecumberri, Ramon; Larocca, Alessandra; Cook, Gordon; Engelhardt, Monika; Zweegman, Sonja; Delforge, Michel; Maraveyas, Anthony; Lefkou, Eleftheria; Marchetti, Marina; Van de Donk, Niels W. C. J.; Gay, Francesca; Ludwig, Heinz; Einsele, Hermann; San Miguel, Jesus F.; Dimopoulos, Meletios A.; Boccadoro, Mario; Sonneveld, Pieter; Falanga, Anna; Terpos, Evangelos | |
| Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial | 2025 | Richardson, Paul; Beksaç, Meral; Oriol, Albert; Lindsay, Jindriska; Schjesvold, Fredrik; Galli, Monica; Yağcı, Münci; Larocca, Alessandra; Weisel, Katja; Yu, Xin; Donahue, Cynthia; Acosta, Jorge; Peluso, Teresa; Dimopoulos, Meletios | |
| Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma | 2025 | Kaiser, Martin F; Sonneveld, Pieter; Cairns, David A; Raab, Marc S; San-Miguel Izquierdo, Jesús; Zhang, Rick; Acosta, Jorge; Larocca, Alessandra; Popat, Rakesh; Li, Cong; Baertsch, Marc-A; Brown, Sarah R; Lahuerta Palacios, JuanJose; Gandhi, Anita K; Macé, Sandrine; Musto, Pellegrino; Yong, Kwee; Mai, Elias K; Dubin, Franck; Blade, Joan; Capra, Andrea; Cook, Gordon; Bertsch, Uta; Mateos, María-Victoria; Boccadoro, Mario; Jackson, Graham H; Gutiérrez, Norma C; Gay, Francesca; Weinhold, Niels | |
| Carfilzomib–lenalidomide–dexamethasone versus lenalidomide–dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial | 2025 | Bringhen, Sara; Cani, Lorenzo; Antonioli, Elisabetta; Derudas, Daniele; Fazio, Francesca; Larocca, Alessandra; Ronconi, Sonia; Cellini, Claudia; Falcone, Antonietta Pia; Accardi, Fabrizio; Liberati, Anna Marina; Galieni, Piero; Belotti, Angelo; Cafro, Anna Maria; Ria, Roberto; Benevolo, Giulia; Vincelli, Iolanda Donatella; Mannina, Donato; Lotti, Flavia; Bruno, Benedetto; Marasco, Vincenzo; Mazza, Rita; Tosi, Patrizia; Rivolti, Elena; Boccadoro, Mario; D'Agostino, Mattia | |
| Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma | 2024 | Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra | |
| Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor | 2024 | Bertuglia, Giuseppe; Garibaldi, Bruno; Casson, Andrea; Sarina, Barbara; Gay, Francesca; Mercadante, Silvio; Mariotti, Jacopo; D'agostino, Mattia; Taurino, Daniela; Oliva, Stefania; Larocca, Alessandra; Mannina, Daniele; De Philippis, Chiara; Benevolo, Giulia; Francisci, Tiziana; Lorenzi, Marco; Bruno, Benedetto; Santoro, Armando; Bringhen, Sara; Mina, Roberto; Bramanti, Stefania | |
| Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | 2024 | Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A | |
| Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study | 2024 | Schjesvold, Fredrik H.; Ludwig, Heinz; Mateos, Maria‐Victoria; Larocca, Alessandra; Abdulhaq, Haifaa; Norin, Stefan; Thuresson, Marcus; Bakker, Nicolaas A.; Richardson, Paul G.; Sonneveld, Pieter | |
| Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment | 2024 | Oriol, Albert; Dimopoulos, Meletios; Schjesvold, Fredrik; Beksac, Meral; Facon, Thierry; Dhanasiri, Sujith; Guo, Shien; Mu, Yutian; Hong, Kevin; Gentili, Christian; Galli, Monica; Yagci, Munci; Larocca, Alessandra; Richardson, Paul; Weisel, Katja | |
| The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review | 2023 | Mian, Hira; McCurdy, Arleigh; Giri, Smith; Grant, Shakira; Rochwerg, Bram; Winks, Erica; Rosko, Ashley E; Engelhardt, Monika; Pawlyn, Charlotte; Cook, Gordon; Jackson, Graham; Bringhen, Sara; Facon, Thierry; Larocca, Alessandra; Zweegman, Sonja; Wildes, Tanya M | |
| New Strategies for the Treatment of Older Myeloma Patients | 2023 | Larocca, Alessandra; Cani, Lorenzo; Bertuglia, Giuseppe; Bruno, Benedetto; Bringhen, Sara | |
| Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma | 2023 | Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto | |
| Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study | 2022 | Larocca A.; Leleu X.; Touzeau C.; Blade J.; Paner A.; Mateos M.-V.; Cavo M.; Maisel C.; Alegre A.; Oriol A.; Raptis A.; Rodriguez-Otero P.; Mazumder A.; Laubach J.; Nadeem O.; Sandberg A.; Orre M.; Torrang A.; Bakker N.A.; Richardson P.G. | |
| Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study | 2022 | Efficace, Fabio; Gaidano, Gianluca; Petrucci, Maria Teresa; Niscola, Pasquale; Cottone, Francesco; Codeluppi, Katia; Antonioli, Elisabetta; Tafuri, Agostino; Larocca, Alessandra; Potenza, Leonardo; Fozza, Claudio; Pastore, Domenico; Rigolin, Gian Matteo; Offidani, Massimo; Romano, Alessandra; Kyriakou, Charalampia; Cascavilla, Nicola; Gozzetti, Alessandro; Derudas, Daniele; Vignetti, Marco; Cavo, Michele | |
| Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel | 2022 | De Stefano, Valerio; Larocca, Alessandra; Carpenedo, Monica; Cavo, Michele; Di Raimondo, Francesco; Falanga, Anna; Offidani, Massimo; Petrucci, Maria Teresa; Ruggeri, Marco; Santi, Roberto Mario; Barosi, Giovanni |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile